濮阳东方医院治阳痿非常好濮阳东方男科医院线上挂号,濮阳东方专家怎么样,濮阳东方医院割包皮价格收费透明,濮阳东方医院治阳痿技术值得放心,濮阳东方妇科收费透明,濮阳东方医院男科治阳痿口碑好很放心,濮阳市东方医院评价很高

BEIJING, Jan. 7 (Xinhua) -- The two-day National Financial Work Conference concluded Saturday, laying out development plans for the financial sector in the coming five years, according to a statement released after the meeting.Chinese Premier Wen Jiabao was present at the conference and delivered a keynote speech.Such a conference is held every five years. Similar meetings were held in 1997, 2002 and 2007.

BEIJING, Nov. 15 (Xinhua) -- Police from China and Angola have jointly busted a criminal gang that kidnapped Chinese females and forced them into prostitution in Angola, according to China's Ministry of Public Security on Tuesday.Police rescued 19 Chinese females during the operation on Oct. 25, when 11 suspects were arrested in Angola and five were caught in China, according to a statement from the ministry.Those female victims and suspects have been transferred back to China, said the statement.In order to boost international cooperation against human trafficking, China had ratified the Protocol to Prevent, Suppress and Punish Trafficking in Persons, Especially Women and Children, supplementing the United Nations Convention against Transnational Organized Crime, in February 2010.Moreover, Chinese police have entered into cooperation agreements with more than 50 countries, which contain anti-human trafficking terms.

HEFEI, Nov. 25 (Xinhua) -- China's leading private automaker, Chery Automobile Co., Ltd., is expected to export a record 170,000 units of vehicles in 2011, marking the highest annual export figure in the company's history, a company manager said Friday.Chery exported 135,556 units of vehicles in the first ten months of this year, up 77.3 percent from a year earlier. This total accounts for 35.3 percent of total passenger vehicle exports of domestic brands, said Feng Ping, deputy general manager of Chery International.The central Anhui province-based carmaker started exporting cars in 2001, when it sold ten cars to Syria, and has since led export sales amongst Chinese automakers.The company exports its products to more than 80 countries and regions, and has established 3 research institutions, a service network of 1,000 dealers and more than 800 service stations overseas.

BEIJING, Jan. 7 (Xinhua) -- China's land supply went up 37 percent year-on-year in 2011 amid the government's tightening measure on commercial property market, according to the Ministry of Land and Resources (MLR) on Saturday. Most of the land supply last year went to the country's 10 million government-subsidized affordable housing units that began construction in 2011, according to MLR.In the meantime, land supply for commercial residential housing totaled about 96,700 hectares last year, up only 4 percent from previous year.Planned land supply quota for construction last year were up 16.25 percent year-on-year from 180,000 hectares in 2010.

WASHINGTON, Dec. 7 (Xinhua) -- The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida.Their report, published on-line Wednesday in Gynecologic Oncology, suggests that this combination, ixabepilone and sunitinib, might offer a much needed treatment option for women with advanced ovarian cancer.Neither drug is approved for use in ovarian cancer. Ixabepilone is a chemotherapy drug that, like other taxane drugs, targets the microtubules and stops dividing cells from forming a spindle. It has been approved for use in metastatic breast cancer. Sunitinib, approved for use in kidney cancer, belongs to a class of tyrosine kinase inhibitors that stops growth signals from reaching inside cancer cells.When caught at late stages, ovarian cancer is often fatal because it progressively stops responding to the chemotherapy drugs used to treat it."Women die from ovarian cancer because their tumors become resistant to chemotherapy, so a drug that might be able to reduce that resistance -- which may be what this combination of agents is doing -- would be a boon to treatment of this difficult cancer," says study coauthor Gerardo Colon-Otero.The finding also highlights the importance of the role of a molecule, RhoB, that the researchers say is activated by the drug duo. It might be a potential biomarker that may help identify patients who might benefit from such combination therapy, the researchers say.